Background: Biomarker-driven molecular imaging has emerged as an integral part of cancer
precision radiotherapy. The use of molecular imaging probes, including nanoprobes, have …

Cancer, as one of the leading causes of death worldwide, drives the advancement of cutting-
edge technologies for cancer treatment. Transition-metal-based nanozymes emerge as …

Though immunogenic cell death (ICD) has garnered significant attention in the realm of
anticancer therapies, effectively stimulating strong immune responses with minimal side …

Radiotherapy (RT) uses ionizing radiation to eradicate localized tumors and, in rare cases,
control tumors outside of the irradiated fields via stimulating an antitumor immune response …

Radiotherapy, a widely used therapeutic strategy for esophageal squamous cell carcinoma
(ESCC), is always limited by radioresistance of tumor tissues and side‐effects on normal …

Metastasis causes greater than 90% of cancer-associated deaths, presenting huge
challenges for detection and efficient treatment of cancer due to its high heterogeneity and …

Neoantigens play a pivotal role in the field of tumour therapy, encompassing the stimulation
of anti-tumour immune response and the enhancement of tumour targeting capability …

Radiotherapy is inevitably accompanied by some degree of radiation resistance, which
leads to local recurrence and even therapeutic failure. To overcome this limitation, herein …

Natural living materials serving as biotherapeutics exhibit great potential for treating various
diseases owing to their immunoactivity, tissue targeting, and other biological activities. In this …

Though platinum (Pt)‐based complexes have been recently exploited as immunogenic cell
death (ICD) inducers for activating immunotherapy, the effective activation of sufficient …